Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Veterinary Ophthalmology|March 12, 2024
Superficial keratectomy for the treatment of spontaneous chronic corneal epithelial defects in dogsWilliam Irving, Paul McCarthy, Benjamin Reynolds, et al.
Veterinary Ophthalmology|July 7, 2023
Effect of dexmedetomidine added to retrobulbar blockade with lignocaine and bupivacaine in dogs undergoing enucleation surgeryWilliam Irving, Matthew Annear, Cameron Whittaker, et al.
Implementation Science : IS|May 4, 2017
Provision of peer specialist services in VA patient aligned care teams: protocol for testing a cluster randomized implementation trialMatthew Chinman, Karin Daniels, Jeff Smith, et al.
JAMIA Open|January 28, 2020
Reimagining the research-practice relationship: policy recommendations for informatics-enabled evidence-generation across the US health systemPeter J Embi, Rachel Richesson, Jessica Tenenbaum, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 13, 2006
Thromboprophylaxis in medically ill patients at risk for venous thromboembolismEdward Burleigh, Cheng Wang, David Foster, et al.
Pharmacology Research & Perspectives|March 11, 2020
Population pharmacokinetic and exposure-response analysis of eptinezumab in the treatment of episodic and chronic migraineBrian Baker, Barbara Schaeffler, Martin Beliveau, et al.
Clinical Pharmacology and Therapeutics|February 14, 2022
In Vivo Cellular Expansion of Lisocabtagene Maraleucel and Association With Efficacy and Safety in Relapsed/Refractory Large B-Cell LymphomaKen Ogasawara, James Lymp, Timothy Mack, et al.
Nuclear Medicine and Biology|May 15, 2003
Aminocarboxylate complexes and octreotide complexes with no carrier added 177Lu, 166Ho and 149PmWen Ping Li, C Jeff Smith, Cathy S Cutler, et al.
Cephalalgia : an International Journal of Headache|June 26, 2019
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trialDavid W Dodick, Richard B Lipton, Stephen Silberstein, et al.
Clinical Therapeutics|November 30, 2020
Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 StudyTimothy R Smith, Marina Janelidze, George Chakhava, et al.
Pageof 8